As of Jun 30
| -0.31 / -1.06%|
The 11 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 38.00, with a high estimate of 48.00 and a low estimate of 28.00. The median estimate represents a +31.85% increase from the last price of 28.82.
The current consensus among 12 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.